Skip to main content

Johannes Levin, MD

Chief Medical Officer, MODAG at LMU Klinikum, Department of Neurology

Professor for Clinical Neurodegeneration at MODAG GmbH

Location: Wendelsheim Germany

Johannes Levin is chief medical officer of MODAG and a full professor of clinical neurodegeneration and head of the outpatient clinic for neurodegenerative diseases at Ludwig-Maximilian-University (LMU) in Munich. He continues to exercise these responsibilities at a 50% capacity-rate. He also serves as deputy head of clinical research at the German Center for Neurodegenerative Diseases (DZNE) in Munich. Dr. Levin studied medicine at LMU, Universidad de Granada (Spain) and Harvard Medical School (Cambridge, MA, USA), and he holds a Doctor of Medicine from the LMU. He is a board-certified neurologist at the Bavarian Chamber of Physicians and has published more than 250 scientific papers. His work has contributed to defining the natural history and treatment of neurodegenerative diseases. Dr. Levin served as principal investigator in many clinical studies, including the largest interventional Multiple System Atrophy (MSA) trial in Germany and international cohort studies such as the Dominantly Inherited Alzheimer’s Network (DIAN).

Associated Grants

  • A Phase I Retest Study of Imaging Tracer MODAG-005 in Parkinson’s Disease, Multiple System Atrophy and Healthy Volunteers


  • Pet Imaging to Determine Regional and Temporal Trajectories of Reactive Astrocytosis in Parkinson’s Disease


  • Pharmacokinetics, Food Effects, Safety and Tolerability of Aggregation Inhibitor Anle138b in Parkinson´s Disease


  • Anle138b Clinical Phase 1 Studies: Food Effect, Safety and Tolerability as well as Pharmacokinetics in Parkinson´s Disease Patients


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.